Amyloid beta from axons and dendrites reduces local spine number and plasticity
暂无分享,去创建一个
Roberto Malinow | Wei Wei | R. Malinow | Wei Wei | S. Sisodia | L. N. Nguyen | H. Kessels | Sangram Sisodia | Louis N Nguyen | Helmut W Kessels | Hiroaki Hagiwara | Hiroaki Hagiwara
[1] D. Peterson,et al. Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice , 2002, The Journal of Neuroscience.
[2] D. Bertrand,et al. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. , 2007, Annual review of pharmacology and toxicology.
[3] W. K. Cullen,et al. Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.
[4] J. David Sweatt,et al. β-Amyloid Peptide Activates α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes* , 2002, The Journal of Biological Chemistry.
[5] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[6] Steven Mennerick,et al. Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.
[7] W. K. Cullen,et al. Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization , 2008, The Journal of Neuroscience.
[8] D. Selkoe,et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.
[9] Dominic M. Walsh,et al. Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation , 2005, The Journal of Neuroscience.
[10] S. Davis,et al. Generation of Aggregated β-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits , 2001, The Journal of Neuroscience.
[11] J. Sweatt,et al. beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. , 2002, The Journal of biological chemistry.
[12] G. Perry,et al. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] K. Kosik,et al. Intraneuronal compartments of the amyloid precursor protein , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[14] T. Bliss,et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.
[15] Nicola Vanacore,et al. Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials , 2007, PLoS medicine.
[16] S. Halpain,et al. Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-β protein , 2007, Molecular and Cellular Neuroscience.
[17] D. Selkoe,et al. Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[18] P. Greengard,et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses , 2005, Neurobiology of Disease.
[19] P. T. Nguyen,et al. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy , 2005, The Journal of Neuroscience.
[20] J. R.,et al. Quantitative analysis , 1892, Nature.
[21] J. Buxbaum,et al. Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path , 1998, The Journal of Neuroscience.
[22] R. Malinow,et al. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.
[23] F. Engert,et al. Dendritic spine changes associated with hippocampal long-term synaptic plasticity , 1999, Nature.
[24] J. Hardy,et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. , 2000, Nature.
[25] C. Finch,et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[26] K. Svoboda,et al. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. , 1999, Science.
[27] O. Vitolo,et al. Amyloid β peptide adversely affects spine number and motility in hippocampal neurons , 2006, Molecular and Cellular Neuroscience.
[28] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[29] T. Lanz,et al. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype , 2003, Neurobiology of Disease.
[30] D. Price,et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[31] Mark Bowlby,et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] Weiming Xia,et al. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. , 2009, Archives of neurology.
[33] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[34] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[35] D. Price,et al. Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Aβ Amyloidosis , 2002, The Journal of Neuroscience.
[36] David M Holtzman,et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.
[37] Dominic M. Walsh,et al. Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.
[38] C. Kaether,et al. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. , 2000, Molecular biology of the cell.
[39] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[40] Roberto Malinow,et al. Glutamate Receptor Exocytosis and Spine Enlargement during Chemically Induced Long-Term Potentiation , 2006, The Journal of Neuroscience.
[41] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[42] S. Small,et al. Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis , 2006, Neuron.
[43] A. Fine,et al. Ultrastructural Distribution of the α7 Nicotinic Acetylcholine Receptor Subunit in Rat Hippocampus , 2001, The Journal of Neuroscience.
[44] G. Collingridge,et al. Low-frequency activation of the NMDA receptor system can prevent the induction of LTP , 1989, Neuroscience Letters.
[45] J. Lisman,et al. Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. , 2004, Journal of neurophysiology.
[46] W. K. Cullen,et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. , 2005, Nature medicine.
[47] D. Holtzman,et al. Treatment with an Amyloid-β Antibody Ameliorates Plaque Load, Learning Deficits, and Hippocampal Long-Term Potentiation in a Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[48] I. Jones,et al. Alpha bungarotoxin-1.4nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors , 2004, Journal of Neuroscience Methods.
[49] J. Hardy,et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.
[50] J. Changeux,et al. Use of a snake venom toxin to characterize the cholinergic receptor protein. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[51] W. Klein,et al. Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.
[52] G. Ellis‐Davies,et al. Structural basis of long-term potentiation in single dendritic spines , 2004, Nature.
[53] R. Prinjha,et al. Aβ1–42 reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: A quantitative analysis , 2008, Journal of Neuroscience Methods.
[54] J. Ting,et al. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms , 2007, Proceedings of the National Academy of Sciences.
[55] D. Holtzman,et al. Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[56] W. Klein,et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[57] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.
[58] D. Budai,et al. Enhancement of NMDA responses by &bgr;-amyloid peptides in the hippocampus in vivo , 2004, Neuroreport.